M. Mamas

First name
M.
Middle name
A.
Last name
Mamas
Cipolletta, E., Tata, L. J., Nakafero, G., Avery, A. J., Mamas, M. A., & Abhishek, A. (2022). Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout. Jama, 328, 440-450. http://doi.org/10.1001/jama.2022.11390
View
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Wilkinson, C., Mamas, M. A., et al. (2022). Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals. Lancet Reg Health Eur, 17, 100386. http://doi.org/10.1016/j.lanepe.2022.100386
View
Ajabnoor, A. M., Zghebi, S. S., Parisi, R., Ashcroft, D. M., Rutter, M. K., Doran, T., et al. (2022). Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study. Plos Med, 19, e1004003. http://doi.org/10.1371/journal.pmed.1004003
View
Jordan, K. P., Rathod-Mistry, T., Bailey, J., Chen, Y., Clarson, L., Denaxas, S., et al. (2022). Long-Term Cardiovascular Risk and Management of Patients Recorded in Primary Care With Unattributed Chest Pain: An Electronic Health Record Study. J Am Heart Assoc, 11, e023146. http://doi.org/10.1161/jaha.121.023146
View
Wright, A. K., Carr, M. J., Kontopantelis, E., Leelarathna, L., Thabit, H., Emsley, R., et al. (2022). Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc21-1113
View
Wright, A. K., Kontopantelis, E., Emsley, R., Buchan, I. E., Mamas, M. A., Sattar, N., et al. (2019). Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities. Circulation. http://doi.org/10.1161/circulationaha.118.039100
View
Nowakowska, M., Zghebi, S. S., Ashcroft, D. M., Buchan, I., Chew-Graham, C., Holt, T., et al. (2019). The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med. http://doi.org/10.1186/s12916-019-1373-y
View
Nakafero, G., Grainge, M., Valdes, A., Townsend, N., Mallen, C., Zhang, W., et al. (2019). Do beta-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink. BMJ Open. http://doi.org/10.1136/bmjopen-2019-032050
View
Lawson, C. A., Zaccardi, F., Squire, I., Ling, S., Davies, M. J., Lam, C. S. P., et al. (2019). 20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study. Lancet Public Health. http://doi.org/10.1016/s2468-2667(19)30108-2
View
Ismail, N., Jordan, K. P., Kadam, U. T., Edwards, J. J., Kinnaird, T., & Mamas, M. A. (2019). Bleeding After Hospital Discharge Following Acute Coronary Syndrome: Incidence, Types, Timing, and Predictors. J Am Heart Assoc. http://doi.org/10.1161/jaha.119.013679
View